 | • レポートコード：GIR201112603 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、インスリン様成長因子1受容体の世界市場を調査対象にし、インスリン様成長因子1受容体の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（BI-893923、CT-707、1R-E1、ATL-1101、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Astellas Pharma Inc.、Genmab A/S、Boehringer Ingelheim GmbH、AstraZeneca Plc、F. Hoffmann-La Roche Ltd.、Axelar AB、Insmed Incorporated、Eli Lilly and Company、Bristol-Myers Squibb Company、Immunomedics, Inc.、ProteoThera, Inc.、Merck & Co., Inc.、PharmAbcine, Inc.、Merrimack Pharmaceuticals, Inc.、Novartis AG ・メーカー別販売量、売上、市場シェア ・インスリン様成長因子1受容体の地域別市場分析 ・インスリン様成長因子1受容体の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・インスリン様成長因子1受容体のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・インスリン様成長因子1受容体のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・インスリン様成長因子1受容体の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・インスリン様成長因子1受容体の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・インスリン様成長因子1受容体の種類別市場規模2015-2020：BI-893923、CT-707、1R-E1、ATL-1101、その他 ・インスリン様成長因子1受容体の用途別市場規模2015-2020：病院、クリニック、その他 ・インスリン様成長因子1受容体の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Insulin Like Growth Factor 1 Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Insulin Like Growth Factor 1 Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Insulin Like Growth Factor 1 Receptor market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Insulin Like Growth Factor 1 Receptor market has been segmented into
BI-893923
CT-707
1R-E1
ATL-1101
Others
By Application, Insulin Like Growth Factor 1 Receptor has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Insulin Like Growth Factor 1 Receptor market presented in the report. This section sheds light on the sales growth of different regional and country-level Insulin Like Growth Factor 1 Receptor markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Insulin Like Growth Factor 1 Receptor market.
The report offers in-depth assessment of the growth and other aspects of the Insulin Like Growth Factor 1 Receptor market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Insulin Like Growth Factor 1 Receptor Market Share Analysis
Insulin Like Growth Factor 1 Receptor competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Insulin Like Growth Factor 1 Receptor sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Insulin Like Growth Factor 1 Receptor sales, revenue and market share for each player covered in this report.
The major players covered in Insulin Like Growth Factor 1 Receptor are:
Astellas Pharma Inc.
Genmab A/S
Boehringer Ingelheim GmbH
AstraZeneca Plc
F. Hoffmann-La Roche Ltd.
Axelar AB
Insmed Incorporated
Eli Lilly and Company
Bristol-Myers Squibb Company
Immunomedics, Inc.
ProteoThera, Inc.
Merck & Co., Inc.
PharmAbcine, Inc.
Merrimack Pharmaceuticals, Inc.
Novartis AG
Among other players domestic and global, Insulin Like Growth Factor 1 Receptor market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Insulin Like Growth Factor 1 Receptor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Insulin Like Growth Factor 1 Receptor, with price, sales, revenue and global market share of Insulin Like Growth Factor 1 Receptor in 2018 and 2019.
Chapter 3, the Insulin Like Growth Factor 1 Receptor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Insulin Like Growth Factor 1 Receptor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Insulin Like Growth Factor 1 Receptor market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Insulin Like Growth Factor 1 Receptor sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Insulin Like Growth Factor 1 Receptor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Insulin Like Growth Factor 1 Receptor Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 BI-893923
1.2.3 CT-707
1.2.4 1R-E1
1.2.5 ATL-1101
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Insulin Like Growth Factor 1 Receptor Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Overview of Global Insulin Like Growth Factor 1 Receptor Market
1.4.1 Global Insulin Like Growth Factor 1 Receptor Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Astellas Pharma Inc.
2.1.1 Astellas Pharma Inc. Details
2.1.2 Astellas Pharma Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Astellas Pharma Inc. SWOT Analysis
2.1.4 Astellas Pharma Inc. Product and Services
2.1.5 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Genmab A/S
2.2.1 Genmab A/S Details
2.2.2 Genmab A/S Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Genmab A/S SWOT Analysis
2.2.4 Genmab A/S Product and Services
2.2.5 Genmab A/S Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Boehringer Ingelheim GmbH
2.3.1 Boehringer Ingelheim GmbH Details
2.3.2 Boehringer Ingelheim GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Boehringer Ingelheim GmbH SWOT Analysis
2.3.4 Boehringer Ingelheim GmbH Product and Services
2.3.5 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 AstraZeneca Plc
2.4.1 AstraZeneca Plc Details
2.4.2 AstraZeneca Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AstraZeneca Plc SWOT Analysis
2.4.4 AstraZeneca Plc Product and Services
2.4.5 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 F. Hoffmann-La Roche Ltd.
2.5.1 F. Hoffmann-La Roche Ltd. Details
2.5.2 F. Hoffmann-La Roche Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 F. Hoffmann-La Roche Ltd. SWOT Analysis
2.5.4 F. Hoffmann-La Roche Ltd. Product and Services
2.5.5 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Axelar AB
2.6.1 Axelar AB Details
2.6.2 Axelar AB Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Axelar AB SWOT Analysis
2.6.4 Axelar AB Product and Services
2.6.5 Axelar AB Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Insmed Incorporated
2.7.1 Insmed Incorporated Details
2.7.2 Insmed Incorporated Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Insmed Incorporated SWOT Analysis
2.7.4 Insmed Incorporated Product and Services
2.7.5 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly and Company
2.8.1 Eli Lilly and Company Details
2.8.2 Eli Lilly and Company Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly and Company SWOT Analysis
2.8.4 Eli Lilly and Company Product and Services
2.8.5 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bristol-Myers Squibb Company
2.9.1 Bristol-Myers Squibb Company Details
2.9.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bristol-Myers Squibb Company SWOT Analysis
2.9.4 Bristol-Myers Squibb Company Product and Services
2.9.5 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Immunomedics, Inc.
2.10.1 Immunomedics, Inc. Details
2.10.2 Immunomedics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Immunomedics, Inc. SWOT Analysis
2.10.4 Immunomedics, Inc. Product and Services
2.10.5 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 ProteoThera, Inc.
2.11.1 ProteoThera, Inc. Details
2.11.2 ProteoThera, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 ProteoThera, Inc. SWOT Analysis
2.11.4 ProteoThera, Inc. Product and Services
2.11.5 ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Merck & Co., Inc.
2.12.1 Merck & Co., Inc. Details
2.12.2 Merck & Co., Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Merck & Co., Inc. SWOT Analysis
2.12.4 Merck & Co., Inc. Product and Services
2.12.5 Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 PharmAbcine, Inc.
2.13.1 PharmAbcine, Inc. Details
2.13.2 PharmAbcine, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 PharmAbcine, Inc. SWOT Analysis
2.13.4 PharmAbcine, Inc. Product and Services
2.13.5 PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Merrimack Pharmaceuticals, Inc.
2.14.1 Merrimack Pharmaceuticals, Inc. Details
2.14.2 Merrimack Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Merrimack Pharmaceuticals, Inc. SWOT Analysis
2.14.4 Merrimack Pharmaceuticals, Inc. Product and Services
2.14.5 Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Novartis AG
2.15.1 Novartis AG Details
2.15.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Novartis AG SWOT Analysis
2.15.4 Novartis AG Product and Services
2.15.5 Novartis AG Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Insulin Like Growth Factor 1 Receptor Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Insulin Like Growth Factor 1 Receptor Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Insulin Like Growth Factor 1 Receptor Manufacturer Market Share in 2019
3.3.2 Top 6 Insulin Like Growth Factor 1 Receptor Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Insulin Like Growth Factor 1 Receptor Sales, Revenue and Market Share by Regions
4.1.1 Global Insulin Like Growth Factor 1 Receptor Sales and Market Share by Regions (2015-2020)
4.1.2 Global Insulin Like Growth Factor 1 Receptor Revenue and Market Share by Regions (2015-2020)
4.2 North America Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
4.3 Europe Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
4.5 South America Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Insulin Like Growth Factor 1 Receptor Sales, Revenue and Market Share by Country
5.1.1 North America Insulin Like Growth Factor 1 Receptor Sales and Market Share by Country (2015-2020)
5.1.2 North America Insulin Like Growth Factor 1 Receptor Revenue and Market Share by Country (2015-2020)
5.2 United States Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
5.3 Canada Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
5.4 Mexico Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Insulin Like Growth Factor 1 Receptor Sales, Revenue and Market Share by Country
6.1.1 Europe Insulin Like Growth Factor 1 Receptor Sales and Market Share by Country (2015-2020)
6.1.2 Europe Insulin Like Growth Factor 1 Receptor Revenue and Market Share by Country (2015-2020)
6.2 Germany Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
6.3 UK Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
6.4 France Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
6.5 Russia Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
6.6 Italy Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Insulin Like Growth Factor 1 Receptor Revenue and Market Share by Regions (2015-2020)
7.2 China Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
7.3 Japan Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
7.4 Korea Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
7.5 India Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
7.7 Australia Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Insulin Like Growth Factor 1 Receptor Sales, Revenue and Market Share by Country
8.1.1 South America Insulin Like Growth Factor 1 Receptor Sales and Market Share by Country (2015-2020)
8.1.2 South America Insulin Like Growth Factor 1 Receptor Revenue and Market Share by Country (2015-2020)
8.2 Brazil Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
8.3 Argentina Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Insulin Like Growth Factor 1 Receptor Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
9.3 Turkey Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
9.4 Egypt Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
9.5 South Africa Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Insulin Like Growth Factor 1 Receptor Sales and Market Share by Type (2015-2020)
10.2 Global Insulin Like Growth Factor 1 Receptor Revenue and Market Share by Type (2015-2020)
10.3 Global Insulin Like Growth Factor 1 Receptor Price by Type (2015-2020)
11 Global Insulin Like Growth Factor 1 Receptor Market Segment by Application
11.1 Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Application (2015-2020)
11.2 Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Application (2015-2020)
11.3 Global Insulin Like Growth Factor 1 Receptor Price by Application (2015-2020)
12 Market Forecast
12.1 Global Insulin Like Growth Factor 1 Receptor Sales, Revenue and Growth Rate (2021-2025)
12.2 Insulin Like Growth Factor 1 Receptor Market Forecast by Regions (2021-2025)
12.2.1 North America Insulin Like Growth Factor 1 Receptor Market Forecast (2021-2025)
12.2.2 Europe Insulin Like Growth Factor 1 Receptor Market Forecast (2021-2025)
12.2.3 Asia-Pacific Insulin Like Growth Factor 1 Receptor Market Forecast (2021-2025)
12.2.4 South America Insulin Like Growth Factor 1 Receptor Market Forecast (2021-2025)
12.2.5 Middle East & Africa Insulin Like Growth Factor 1 Receptor Market Forecast (2021-2025)
12.3 Insulin Like Growth Factor 1 Receptor Market Forecast by Type (2021-2025)
12.3.1 Global Insulin Like Growth Factor 1 Receptor Sales Forecast by Type (2021-2025)
12.3.2 Global Insulin Like Growth Factor 1 Receptor Market Share Forecast by Type (2021-2025)
12.4 Insulin Like Growth Factor 1 Receptor Market Forecast by Application (2021-2025)
12.4.1 Global Insulin Like Growth Factor 1 Receptor Sales Forecast by Application (2021-2025)
12.4.2 Global Insulin Like Growth Factor 1 Receptor Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Insulin Like Growth Factor 1 Receptor Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Insulin Like Growth Factor 1 Receptor by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Insulin Like Growth Factor 1 Receptor Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Major Business
Table 9. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 10. Astellas Pharma Inc. SWOT Analysis
Table 11. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Product and Services
Table 12. Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Genmab A/S Basic Information, Manufacturing Base and Competitors
Table 14. Genmab A/S Insulin Like Growth Factor 1 Receptor Major Business
Table 15. Genmab A/S Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 16. Genmab A/S SWOT Analysis
Table 17. Genmab A/S Insulin Like Growth Factor 1 Receptor Product and Services
Table 18. Genmab A/S Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 20. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Major Business
Table 21. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 22. Boehringer Ingelheim GmbH SWOT Analysis
Table 23. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Product and Services
Table 24. Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 26. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Major Business
Table 27. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 28. AstraZeneca Plc SWOT Analysis
Table 29. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Product and Services
Table 30. AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 32. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Major Business
Table 33. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 34. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 35. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Product and Services
Table 36. F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Axelar AB Basic Information, Manufacturing Base and Competitors
Table 38. Axelar AB Insulin Like Growth Factor 1 Receptor Major Business
Table 39. Axelar AB Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 40. Axelar AB SWOT Analysis
Table 41. Axelar AB Insulin Like Growth Factor 1 Receptor Product and Services
Table 42. Axelar AB Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Insmed Incorporated Basic Information, Manufacturing Base and Competitors
Table 44. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Major Business
Table 45. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 46. Insmed Incorporated SWOT Analysis
Table 47. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Product and Services
Table 48. Insmed Incorporated Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 50. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Major Business
Table 51. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 52. Eli Lilly and Company SWOT Analysis
Table 53. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Product and Services
Table 54. Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 56. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Major Business
Table 57. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 58. Bristol-Myers Squibb Company SWOT Analysis
Table 59. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Product and Services
Table 60. Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Immunomedics, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Major Business
Table 63. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 64. Immunomedics, Inc. SWOT Analysis
Table 65. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Product and Services
Table 66. Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. ProteoThera, Inc. Basic Information, Manufacturing Base and Competitors
Table 68. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Major Business
Table 69. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 70. ProteoThera, Inc. SWOT Analysis
Table 71. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Product and Services
Table 72. ProteoThera, Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table 74. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Major Business
Table 75. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 76. Merck & Co., Inc. SWOT Analysis
Table 77. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Product and Services
Table 78. Merck & Co., Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. PharmAbcine, Inc. Basic Information, Manufacturing Base and Competitors
Table 80. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Major Business
Table 81. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 82. PharmAbcine, Inc. SWOT Analysis
Table 83. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Product and Services
Table 84. PharmAbcine, Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Merrimack Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Major Business
Table 87. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 88. Merrimack Pharmaceuticals, Inc. SWOT Analysis
Table 89. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Product and Services
Table 90. Merrimack Pharmaceuticals, Inc. Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 92. Novartis AG Insulin Like Growth Factor 1 Receptor Major Business
Table 93. Novartis AG Insulin Like Growth Factor 1 Receptor Total Revenue (USD Million) (2018-2019)
Table 94. Novartis AG SWOT Analysis
Table 95. Novartis AG Insulin Like Growth Factor 1 Receptor Product and Services
Table 96. Novartis AG Insulin Like Growth Factor 1 Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Global Insulin Like Growth Factor 1 Receptor Sales by Manufacturer (2018-2019) (K Pcs)
Table 98. Global Insulin Like Growth Factor 1 Receptor Revenue by Manufacturer (2018-2019) (USD Million)
Table 99. Global Insulin Like Growth Factor 1 Receptor Sales by Regions (2015-2020) (K Pcs)
Table 100. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Regions (2015-2020)
Table 101. Global Insulin Like Growth Factor 1 Receptor Revenue by Regions (2015-2020) (USD Million)
Table 102. North America Insulin Like Growth Factor 1 Receptor Sales by Countries (2015-2020) (K Pcs)
Table 103. North America Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries (2015-2020)
Table 104. North America Insulin Like Growth Factor 1 Receptor Revenue by Countries (2015-2020) (USD Million)
Table 105. North America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries (2015-2020)
Table 106. Europe Insulin Like Growth Factor 1 Receptor Sales by Countries (2015-2020) (K Pcs)
Table 107. Europe Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries (2015-2020)
Table 108. Europe Insulin Like Growth Factor 1 Receptor Revenue by Countries (2015-2020) (USD Million)
Table 109. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales by Regions (2015-2020) (K Pcs)
Table 110. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share by Regions (2015-2020)
Table 111. Asia-Pacific Insulin Like Growth Factor 1 Receptor Revenue by Regions (2015-2020) (USD Million)
Table 112. South America Insulin Like Growth Factor 1 Receptor Sales by Countries (2015-2020) (K Pcs)
Table 113. South America Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries (2015-2020)
Table 114. South America Insulin Like Growth Factor 1 Receptor Revenue by Countries (2015-2020) (USD Million)
Table 115. South America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries (2015-2020)
Table 116. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales by Countries (2015-2020) (K Pcs)
Table 117. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries (2015-2020)
Table 118. Middle East & Africa Insulin Like Growth Factor 1 Receptor Revenue by Countries (2015-2020) (USD Million)
Table 119. Middle East & Africa Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries (2015-2020)
Table 120. Global Insulin Like Growth Factor 1 Receptor Sales by Type (2015-2020) (K Pcs)
Table 121. Global Insulin Like Growth Factor 1 Receptor Sales Share by Type (2015-2020)
Table 122. Global Insulin Like Growth Factor 1 Receptor Revenue by Type (2015-2020) (USD Million)
Table 123. Global Insulin Like Growth Factor 1 Receptor Revenue Share by Type (2015-2020)
Table 124. Global Insulin Like Growth Factor 1 Receptor Sales by Application (2015-2020) (K Pcs)
Table 125. Global Insulin Like Growth Factor 1 Receptor Sales Share by Application (2015-2020)
Table 126. Global Insulin Like Growth Factor 1 Receptor Sales Forecast by Regions (2021-2025) (K Pcs)
Table 127. Global Insulin Like Growth Factor 1 Receptor Market Share Forecast by Regions (2021-2025)
Table 128. Global Insulin Like Growth Factor 1 Receptor Sales Forecast by Type (2021-2025) (K Pcs)
Table 129. Global Insulin Like Growth Factor 1 Receptor Market Share Forecast by Type (2021-2025)
Table 130. Global Insulin Like Growth Factor 1 Receptor Sales Forecast by Application (2021-2025)
Table 131. Global Insulin Like Growth Factor 1 Receptor Market Share Forecast by Application (2021-2025)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Insulin Like Growth Factor 1 Receptor Picture
Figure 2. Global Sales Market Share of Insulin Like Growth Factor 1 Receptor by Type in 2019
Figure 3. BI-893923 Picture
Figure 4. CT-707 Picture
Figure 5. 1R-E1 Picture
Figure 6. ATL-1101 Picture
Figure 7. Others Picture
Figure 8. Insulin Like Growth Factor 1 Receptor Sales Market Share by Application in 2018
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Others Picture
Figure 12. Global Insulin Like Growth Factor 1 Receptor Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Insulin Like Growth Factor 1 Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Insulin Like Growth Factor 1 Receptor Sales Market Share by Manufacturer in 2019
Figure 33. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Insulin Like Growth Factor 1 Receptor Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Insulin Like Growth Factor 1 Receptor Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Insulin Like Growth Factor 1 Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Regions (2015-2020)
Figure 40. Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Regions in 2018
Figure 41. North America Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
Figure 42. Europe Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
Figure 44. South America Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020)
Figure 46. North America Insulin Like Growth Factor 1 Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries (2015-2020)
Figure 48. North America Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries in 2018
Figure 49. North America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries in 2018
Figure 51. United States Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Insulin Like Growth Factor 1 Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries in 2019
Figure 57. Germany Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Insulin Like Growth Factor 1 Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Insulin Like Growth Factor 1 Receptor Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Insulin Like Growth Factor 1 Receptor Revenue Market Share by Regions 2019
Figure 65. China Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Insulin Like Growth Factor 1 Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries in 2019
Figure 72. South America Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries in 2019
Figure 73. Brazil Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Insulin Like Growth Factor 1 Receptor Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Insulin Like Growth Factor 1 Receptor Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Insulin Like Growth Factor 1 Receptor Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Insulin Like Growth Factor 1 Receptor Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Insulin Like Growth Factor 1 Receptor Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Insulin Like Growth Factor 1 Receptor Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Insulin Like Growth Factor 1 Receptor Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Insulin Like Growth Factor 1 Receptor Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Insulin Like Growth Factor 1 Receptor Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
線維芽細胞成長因子受容体4の世界市場 2020年 Market Overview The global Fibroblast Growth Factor Receptor 4 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Fibroblas…- インスリン注射ペンの世界市場 2020年 Market Overview The Insulin Injection Pen market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- インスリンペン及びポンプの世界市場 2020年 Market Overview The Insulin Pen and Pump market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- スマートインスリンペンの世界市場 2020年 Market Overview The Smart Insulin Pens market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- インスリンペン針の世界市場 2020年 Market Overview The Insulin Pen Needles market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…